# Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

> **NCT00740064** · PHASE4 · UNKNOWN · sponsor: **Denver Infectious Disease Consultants, PLLC** · enrollment: 30 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Raltegravir and Abacavir/Lamivudine

## Key facts

- **NCT ID:** NCT00740064
- **Lead sponsor:** Denver Infectious Disease Consultants, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740064, "Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00740064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*